Firm behind coronavirus drug faces questions over pricing, potentially cheaper option
skhoward/iStockBy LUCIEN BRUGGEMAN, ABC News
(NEW YORK) -- After initial excitement about the discovery of a promising treatment for some coronavirus patients, executives with Gilead Sciences are now facing harsh criticism over the initial business decisions they’ve made in the... Read More.